Medicare Enrolled

Dr. Kaushik Hazariwala, M.D.

Ophthalmology · Gainesville, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4340 W NEWBERRY RD, Gainesville, FL 32607
3523712800
In practice since 2006 (19 years)
NPI: 1891748430 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hazariwala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hazariwala? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hazariwala

Dr. Kaushik Hazariwala is an ophthalmology specialist in Gainesville, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hazariwala performed 15,115 Medicare services across 2,590 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hazariwala received a total of $880 from 9 pharmaceutical and/or device companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hazariwala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in FL $880 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 63988 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
15,115
Medicare services
Top 9% in FL for ophthalmology
2,590
Unique beneficiaries
$144
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~796 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab) 7,140 $29 $84
Aflibercept eye injection (Eylea) 2,344 $693 $1,200
Retinal imaging (OCT scan) 2,113 $29 $70
Eye injection for retinal disease 1,321 $92 $246
Eye exam, established patient, focused 1,188 $62 $100
Comprehensive eye exam, established patient 562 $88 $140
Compounded drug, not otherwise classified 229 $66 $300
Comprehensive eye exam, new patient 163 $98 $180
Retinal photography (fundus photo) 42 $25 $100
Extended exam of the back part of the eye with retinal drawing 13 $18 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$880
Total received (2018-2024)
Avg $147/year across 6 years
Bottom 33% in FL for ophthalmology
9
Companies
24
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$880 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$272
2023
$152
2022
$72
2020
$12
2019
$351
2018
$21

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$327
Astellas Pharma US Inc
$132
Mallinckrodt Enterprises LLC
$121
Genentech USA, Inc.
$118
Spark Therapeutics, Inc.
$86
ABBVIE INC.
$48
Bausch & Lomb, a division of Bausch Health US, LLC
$21
Apellis Pharmaceuticals, Inc.
$15
Alimera Sciences, Inc.
$12
Top 3 companies account for 65.9% of total payments
Associated products mentioned in payments ›
ACTHAR · EYLEA · EYLEA HD · Iluvien · Izervay · OZURDEX · Syfovre · VABYSMO · VISUDYNE · Vabysmo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $6 per 100 Medicare services performed
Looking for an ophthalmology specialist in Gainesville?
Compare ophthalmologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
44
Per 100K population
15.6
County median income
$59,659
Nearest hospital
HCA FLORIDA NORTH FLORIDA HOSPITAL
3.5 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hazariwala is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hazariwala experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Hazariwala performed 7,140 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hazariwala receive payments from pharmaceutical companies?
Yes. Dr. Hazariwala received a total of $880 from 9 companies across 24 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hazariwala's costs compare to other ophthalmologists in Gainesville?
Dr. Hazariwala's average Medicare payment per service is $144. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hazariwala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Ophthalmologists in Gainesville
Browse ophthalmologists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Ophthalmologists in FL
Ophthalmologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Ophthalmologists in FL
Which FL ophthalmologists receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Mallinckrodt Enterprises LLC Payments to Doctors
See all physicians who received payments from Mallinckrodt Enterprises LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →